In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells

Journal: Nature Communications

Published: 2020-10-08

DOI: 10.1038/s41467-020-18875-x

Affiliations: 10

Authors: 16

Go to article
Institutions Share
Spanish National Cancer Research Centre (CNIO), Spain 0.53
University of Barcelona (UB), Spain 0.18
Sant Joan de Déu Research Institute (IRSJD), Spain 0.06
SJD Barcelona Children's Hospital​ for Maternal and Child Health, BMA, Spain 0.06
Centre for Energy, Environment and Technology (CIEMAT), Spain 0.04
Biomedical Research Networking Center on Rare Diseases (CIBERER), Spain 0.04
Autonomous University of Madrid (UAM), Spain 0.04
Catalan Institution for Research and Advanced Studies (ICREA), Spain 0.02
Biomedical Research Networking Centers (CIBER), Spain 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER